Zhang et al. [61] showed that naringenin exerts a pharmacological effect against the progression of cardiac hypertrophy induced by pressure overload through inhibiting JNK, ERK, and PI3K/Akt signaling pathways. The gene discussed is AKT1; the disease is cardiac hypertrophy.